Challenge 

As the 2024 U.S. elections approached, global consulting firm BRG sought to showcase its subject matter experts who could speak on how the healthcare and life sciences industries could potentially be impacted.  

But with reporters’ inboxes filling up ahead of Election Day, pursuing time consuming one-on-one interviews with busy reporters would prove logistically challenging—and limit the reach of BRG experts’ insightful analyses.  

To reach as many reporters as possible, BRG needed a different strategy: one that strengthened its authority on complex industry issues facing policymakers and business leaders around the country.     

Solution 

To maximize BRG’s earned media reach, Greentarget proposed holding a roundtable with an array of top-tier and trade journalists covering healthcare policy and the election, allowing the firm to reach multiple reporters in one fell swoop. By bringing BRG experts and influential reporters together for an on-the-record conversation, the roundtable would not only display BRG’s authority on policy matters but also position the firm as a go-to resource for future commentary.  

With five BRG spokespeople confirmed for the event—including a former White House policy advisor and the former chief counsel of the Food and Drug Administration—Greentarget also helped BRG’s experts prepare talking points and presentations to reference during the roundtable to help ensure their messages resonated. After the roundtable, Greentarget used these talking points to secure additional stories with attendees and other key reporters.  

Results 

Greentarget secured 30 RSVPs from reporters at outlets such as FiercePharma, Forbes, Inside Health Policy, Clinical Trials Arena, Medcity News, Medpage Today, Modern Healthcare, Pink Sheet, and STAT News, among others.  

The roundtable resulted in 20 pieces of coverage in top-tier outlets such The Wall Street Journal, Reuters, Barron’s, MarketWatch, Politico, and Fortune—as well as key industry publications like Medical Economics, FierceHealthcare, FiercePharma and STAT. Stories covered everything from Robert F. Kennedy Jr.’s potential health policy agenda to the new administration’s approach to drug pricing, exhibiting the diverse experience and expertise of BRG’s healthcare team.  

Demonstrating the value of a strong PR program, the event also generated new business leads for BRG’s healthcare practice. To build on the first roundtable’s resounding success, similar events are in the works for 2025.